Long Non-Coding RNA MALAT1 Regulates HMOX1 in Sickle Cell Disease-Associated Pulmonary Hypertension
Cells · 2026
DOI: 10.3390/cells15020154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Viranuj Sueblinvong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Emory University School of Medicine, Atlanta, GA 30322, US…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Hypertension, Pulmonary, Anemia, Sickle Cell, Heme Oxygenase-1. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, United States Department of Veterans Affairs, VA BLR&D Merit Review Award.
Abstract (Originalsprache)
Pulmonary hypertension (PH) causes morbidity and mortality in sickle cell disease (SCD). The release of heme during hemolysis triggers endothelial dysfunction and contributes to PH. Long non-coding RNAs (lncRNAs) may play a pivotal role in endothelial dysfunction and PH pathogenesis. This study assessed the regulatory role of the lncRNA–heme oxygenase-1 (HMOX1) axis in SCD-associated PH pathogenesis. Total RNAs were isolated from the lungs of 15–17-week-old sickle cell (SS) mice and littermate controls (AA) mice and subjected to lncRNA expression profiling using the Arrystar™ lncRNA array. Volcano plot filtering was used to screen for differentially expressed lncRNAs and mRNAs with statistical significance (fold change > 1.8, p < 0.05). A total of 3915 lncRNAs were upregulated and a total of 3545 lncRNAs were downregulated in the lungs of SS mice compared to AA mice. To validate differentially expressed lncRNAs, six upregulated lncRNAs and six downregulated lncRNAs were selected for quantitative PCR. MALAT1 expression was significantly upregulated in the lungs of SS mice and in hemin-treated human pulmonary artery endothelial cells (HPAECs), suggesting that hemolysis induces MALAT1. Functional studies revealed that MALAT1 depletion increased, while MALAT1 overexpression decreased, the endothelial dysfunction markers endothelin-1 (ET-1) and vascular cell adhesion molecule-1 (VCAM1), indicating a protective role of MALAT1 in maintaining endothelial homeostasis. In vivo, adenoviral MALAT1 overexpression attenuated PH, right ventricular hypertrophy (RVH), vascular remodeling, and reduced ET-1 and VCAM1 expression in SS mice. Given that HMOX1 protects endothelial cells during hemolysis, we observed that HMOX1 expression and activity were elevated in SS mouse lungs and hemin-treated HPAECs. HMOX1 knockdown enhanced ET-1 and VCAM1 expression, confirming its endothelial-protective function. Importantly, MALAT1 overexpression increased HMOX1 expression and activity, whereas MALAT1 knockdown reduced HMOX1 levels and mRNA stability. Collectively, these findings identify MALAT1 as a protective regulator that mitigates endothelial dysfunction, vascular remodeling, and PH in SCD, at least in part through the induction of HMOX1. These results suggest that SCD modulates the MALAT1–HMOX1 axis, and further characterization of MALAT1 function may provide new insights into SCD-associated endothelial dysfunction and PH pathogenesis, as well as identify novel therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
- Atlanta Veterans Affairs Healthcare System, Decatur, GA 30033, USA.
- Department of Pediatrics, Division of Hematology, Oncology, and BMT, Emory University School of Medicine, 2015 Uppergate Drive, Atlanta, GA 30322, USA.
- National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Department of Molecular and Cellular Physiology, Louisiana State University Health Science Center, Shreveport, LA 71103, USA.
- Department of Pediatrics, Division of Pulmonology, Asthma, Cystic Fibrosis, and Sleep Medicine, Emory University School of Medicine, 2015 Uppergate Drive, Atlanta, GA 30322, USA.
ORCID-Profile: Viranuj Sueblinvong, David R Archer, Roy L Sutliff, Bum-Yong Kang
Förderung
- NIH HHS
- United States Department of Veterans Affairs
- VA BLR&D Merit Review Award
- Louisiana State University
- NIH National Heart, Lung, and Blood Institute R01 grants
- NIH National Institute of Alcoholism and Abuse grants
- National Center for Advancing Translational Sciences of the National Institutes of Health
Zitieren
APA
Sueblinvong, V., Chang, S. S., Ma, J., Archer, D. R., Ofori-Acquah, S., Sutliff, R. L., Park, C., Hart, C. M., Kopp, B. T., & Kang, B. Y. (2026). Long Non-Coding RNA MALAT1 Regulates HMOX1 in Sickle Cell Disease-Associated Pulmonary Hypertension. Cells. https://doi.org/10.3390/cells15020154
Vancouver
Sueblinvong V, Chang SS, Ma J, Archer DR, Ofori-Acquah S, Sutliff RL, et al. Long Non-Coding RNA MALAT1 Regulates HMOX1 in Sickle Cell Disease-Associated Pulmonary Hypertension. Cells. 2026. doi:10.3390/cells15020154
BibTeX
@article{Sueblinvong2026,
author = {Sueblinvong, Viranuj and Chang, Sarah S and Ma, Jing and Archer, David R and Ofori-Acquah, Solomon and Sutliff, Roy L and Park, Changwon and Hart, C Michael and Kopp, Benjamin T and Kang, Bum-Yong},
title = {Long Non-Coding RNA MALAT1 Regulates HMOX1 in Sickle Cell Disease-Associated Pulmonary Hypertension},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15020154}
}
EUVIMED